Aura Biosciences Inc.
AURA | NASDAQ
$6.36
-$0.08 (-1.24%)
At close: Sep 21, 2026, 4:00 PM ET
$6.43
+$0.07 (+1.10%)
Pre-market:
Sep 22, 2026, 7:56 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 1.3M | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -1.3M | n/a | n/a | n/a |
Operating Income | -112.79M | -96.12M | -84.99M | -60.3M | -35.25M | -22.21M |
Interest Income | 6.63M | 9.43M | 8.59M | 1.86M | 13K | 3 |
Pretax Income | -106.08M | -86.81M | -76.27M | -58.76M | -35.25M | -22.21M |
Net Income | -106.19M | -86.92M | -76.41M | -58.76M | -35.25M | -22.21M |
Selling & General & Admin | 22.49M | 22.81M | 19.76M | 18.06M | 10.09M | 4.16M |
Research & Development | 90.3M | 73.3M | 63.94M | 42.24M | 25.16M | 18.04M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 112.79M | 96.12M | 83.7M | 60.3M | 35.25M | 22.21M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 112.79M | 96.12M | 84.99M | 60.3M | 35.25M | 22.21M |
Income Tax Expense | 108K | 112K | 137K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.34M | 49.65M | 39.62M | 29.94M | 29.21M | 29.22M |
Shares Outstanding (Diluted) | 60.34M | 49.65M | 39.62M | 29.94M | 29.21M | 29.22M |
EPS (Basic) | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 |
EPS (Diluted) | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 |
EBITDA | -104.95M | -85.58M | -74.98M | -57.59M | -34.41M | -21.38M |
EBIT | -106.08M | -86.81M | -76.27M | -58.76M | -35.24M | -22.21M |
Depreciation & Amortization | 1.13M | 1.22M | 1.3M | 1.18M | 831K | 831K |
Add to Watchlist
Select watchlists to add or remove AURA